Advertisement
Pfizer Inc.

Pfizer Inc. (PFE) Stock Overview

Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.

PFENYSE
HealthcareDrug Manufacturers - General
$25.60
$0.10(0.39%)
U.S. Market opens in 16h 26m
Advertisement

Pfizer Inc. (PFE)

Meyka AI Score

Z

Key Financials

Market Cap146B
P/E Ratio19.56
EPS (TTM)$1.31
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$25.57
3 Months$28.17
1 Year Target$26.26

PFE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pfizer Inc. (PFE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.56 and a market capitalization of 146B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.39%
5-Day Change
-0.97%
1-Month Change
-0.31%
3-Month Change
-5.74%
6-Month Change
-0.70%
Year-to-Date (YTD) Change
2.81%
1-Year Change
5.35%
3-Year Change
-35.84%
5-Year Change
-37.07%
All-Time (Max) Change
5860.003%

Contact Information

212 733 2323
66 Hudson Boulevard East, New York City, NY, 10001-2192

Company Facts

810,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions